Novel metabolic subtypes in IDH-mutant gliomas: implications for prognosis and therapy

Abstract Background Although IDH-mutant glioma generally has a better prognosis than their IDH-wildtype counterparts, considerable prognostic heterogeneity persists among patients with the same IDH mutation. Current study has primarily focused on the different IDH statuses or grades, while the metab...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Peng Wang, Jiayi Wang, Zheng Fang, Qiaodong Chen, Ying Zhang, Xiaoguang Qiu, Zhaoshi Bao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-04-01
coleção:	BMC Cancer
Assuntos:	Glioma IDH-mutant Metabolism Transcriptome Gene-expression signature
Acesso em linha:	https://doi.org/10.1186/s12885-025-14176-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!